Carl Decker

Carl Decker, PhD, MBS, currently serves as Associate Director at 89bio, following a tenure as Senior Clinical Scientist at Biomea Fusion, and Lead Clinical Scientist at Genentech. With experience in clinical development, particularly in the fields of diabetes, metabolism, oncology, and hematology, Carl has held diverse roles, including Clinical Development Scientist at Ascendis Pharma A/S, where contributions to early clinical development were significant. Academic involvement includes serving as Adjunct Professor at the University of La Verne, where course design and curriculum development were key responsibilities. Additionally, roles in clinical affairs and research at Axonics, Gilead Sciences, and Keck Graduate Institute showcase expertise in regulatory processes, laboratory operations, and cancer research. Carl holds a Professional Certificate in Artificial Intelligence from the University of California, Berkeley, a PhD in Molecular Bioenergetics, and a Master's degree in Clinical & Regulatory Affairs, complemented by a Bachelor's degree in Biology and Speech Communications.